186 related articles for article (PubMed ID: 11979926)
1. [Estrogen in the treatment of osteoporosis].
Ohta H
Nihon Rinsho; 2002 Mar; 60 Suppl 3():329-39. PubMed ID: 11979926
[No Abstract] [Full Text] [Related]
2. [Vitamin K2 in the treatment of osteoporosis].
Shiraki M
Nihon Rinsho; 2002 Mar; 60 Suppl 3():340-9. PubMed ID: 11979928
[No Abstract] [Full Text] [Related]
3. [Alendronate in the treatment of osteoporosis].
Inaba M
Nihon Rinsho; 2002 Mar; 60 Suppl 3():373-80. PubMed ID: 11979932
[No Abstract] [Full Text] [Related]
4. [Ipriflavone in the treatment of osteoporosis].
Makita K; Ohta H
Nihon Rinsho; 2002 Mar; 60 Suppl 3():359-64. PubMed ID: 11979930
[No Abstract] [Full Text] [Related]
5. [Bisphosphonates: pharmacology and use in the treatment of osteoporosis].
Kishimoto H
Nihon Rinsho; 2002 Mar; 60 Suppl 3():350-8. PubMed ID: 11979929
[No Abstract] [Full Text] [Related]
6. [Treatment of osteoporosis: overview].
Nakamura T
Nihon Rinsho; 2002 Mar; 60 Suppl 3():273-9. PubMed ID: 11979919
[No Abstract] [Full Text] [Related]
7. [Risedronate: clinical usage].
Shiraki M
Nihon Rinsho; 2002 Mar; 60 Suppl 3():529-37. PubMed ID: 11979951
[No Abstract] [Full Text] [Related]
8. [Hypogonadism and osteoporosis].
Chaki O
Nihon Rinsho; 2004 Feb; 62 Suppl 2():693-701. PubMed ID: 15035211
[No Abstract] [Full Text] [Related]
9. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
Ohta H
Clin Calcium; 2004 Oct; 14(10):73-80. PubMed ID: 15577135
[TBL] [Abstract][Full Text] [Related]
10. [Risedronate treatment for osteoporosis].
Kishimoto H
Nihon Rinsho; 2004 Feb; 62 Suppl 2():419-22. PubMed ID: 15035163
[No Abstract] [Full Text] [Related]
11. [Drugs in development for the treatment of osteoporosis: Incadronate].
Ohsawa M; Soda M; Mizunuma H
Nihon Rinsho; 2002 Mar; 60 Suppl 3():538-43. PubMed ID: 11979952
[No Abstract] [Full Text] [Related]
12. [Accumulation of microdamage in bone].
Mori S
Nihon Rinsho; 2007 Nov; 65 Suppl 9():203-8. PubMed ID: 18161107
[No Abstract] [Full Text] [Related]
13. [Role of steroid receptors in osteoporosis].
Inoue S
Nihon Ronen Igakkai Zasshi; 2001 Nov; 38(6):775-7. PubMed ID: 11774721
[No Abstract] [Full Text] [Related]
14. [Contribution of bone quality to fracture risk].
Mori S
Clin Calcium; 2004 Oct; 14(10):33-8. PubMed ID: 15577129
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of fractures with therapeutic agents for osteoporosis].
Hosoi T
Nihon Rinsho; 2004 Feb; 62 Suppl 2():596-601. PubMed ID: 15035197
[No Abstract] [Full Text] [Related]
16. [Guideline for treatment of osteoporosis].
Yamamoto I
Nihon Rinsho; 2002 Mar; 60 Suppl 3():280-7. PubMed ID: 11979920
[No Abstract] [Full Text] [Related]
17. [The results of treatment in the osteoporosis dock--follow up for 9 years].
Takizawa H
Nihon Rinsho; 2002 Mar; 60 Suppl 3():634-41. PubMed ID: 11979963
[No Abstract] [Full Text] [Related]
18. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
Soen S
Nihon Rinsho; 2007 Nov; 65 Suppl 9():325-8. PubMed ID: 18159713
[No Abstract] [Full Text] [Related]
19. [Effect of raloxifene as a SERM on bone metabolism].
Ohta H
Nihon Rinsho; 2006 Apr; 64 Suppl 4():411-8. PubMed ID: 16689343
[No Abstract] [Full Text] [Related]
20. Calcium, estrogen, and progestin in the treatment of osteoporosis.
Breslau NA
Rheum Dis Clin North Am; 1994 Aug; 20(3):691-716. PubMed ID: 7984785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
